NCT03667417View on ClinicalTrials.gov

Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation

RecruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

October 15, 1999

Primary Completion Date

October 15, 2028

Study Completion Date

October 15, 2028

Conditions
Breast CancersOvarian Cancers
Interventions
OTHER

Questionnaires

standardized data collection and 10-year prospective follow-up

Trial Locations (1)

13009

RECRUITING

Institut Paoli-Calmettes, Marseille

All Listed Sponsors
collaborator

UNICANCER - Le Groupe génétique et cancer (GGC)

UNKNOWN

lead

Institut Paoli-Calmettes

OTHER

NCT03667417 - Genetic Predisposition to Breast and Ovarian Cancer: Prospective Study of BRCAx Gene Mutation | Biotech Hunter | Biotech Hunter